This website will close on 30 April 2024. After this date, your content will not be accessible. Please contact for more information.

Proven innovation
Share innovation

Low Carb Program

By Arjun Panesar, DDM Health Added 23rd May, 2019 Updated 17th Nov, 2022

The Low Carb Program is a structured education and behaviour change platform for people with type 2 diabetes, prediabetes, polycystic ovarian syndrome and non-alcoholic fatty liver disease that provides: structured education, resources, and behaviour change support to reduce the amount of sugar in the diet. Peer-reviewed, published outcomes demonstrate patients with type 2 diabetes reduce their HbA1c by 13mmol/mol, 40% eliminate a medication and 26% of patients are in type 2 remission at 1-year.

The program was selected by the NHS Innovation Accelerator for accelerated adoption of the high-impact innovation within primary care. 


The Low Carb Program engages participants in a 16-week structured education course and post-completion engages users in a maintenance and wellness program. The program is available in 11 languages to reduce health inequalities.  

Participants receive tailored education on modifiable risk factors including nutrition, sleep, stress, mental health, smoking cessation and blood glucose testing. The platform is available on iOS, Android, Apple and Android watch, web, and Alexa with over 475,000 users.

The platform comprises:

  • Education: a core 12-week structured therapeutic nutrition and wellness program, personalised to disease type and profile. Past 12 weeks, members participate in new, monthly education modules.
  • Community peer support with over 475,000 members
  • Behaviour change mentoring and goal identification
  • Library of personalised resources, including culturally-specific meal plans and over 2,000 recipe ideas
  • Curated information and educational content updated daily
  • Data insights and AI-led feedback to support sustainable behaviour change

The program augments standard care by providing demonstrated long-term behaviour change.

The platform’s peer-reviewed, published outcomes demonstrate equivalent outcomes to face-to-face care with 8 research studies demonstrating the platform's takeup, effectiveness and impact.

The Low Carb Program is an MHRA regulated Class I Medical Device, QISMET approved for delivery as structured education to people with type 2 diabetes and prediabetes, and selected by the NHS Innovation Accelerator for accelerated adoption within primary care.

Related Innovations